Business Context and Reporting Period
This Form 8-K was filed by Xylem Inc. on August 15, 2016, reporting the entry into a Material Definitive Agreement. The filing details the execution of a Share Purchase Agreement to acquire the direct and indirect subsidiaries of Sensus Worldwide Limited (excluding Sensus Industries Limited).
Key Financial Metrics
- Transaction Consideration: $1,700,000,000 in cash, subject to customary adjustments.
- Financing Structure: The transaction will be financed through a combination of cash on hand, existing credit facilities, and new debt issuance.
- Debt Issuance: Includes up to $1.3 billion in senior unsecured notes.
- Bridge Financing: A 364-day, $1.3 billion senior unsecured bridge facility has been committed by Citigroup Global Markets Inc., Wells Fargo Securities, LLC, and Wells Fargo Bank, National Association.
- Other Metrics: The filing does not provide specific revenue, profit, cash flow, margin, or liquidity figures for the reporting period.
Material Changes
The primary material change is the initiation of a major acquisition. Xylem has entered into a definitive agreement to purchase Sensus subsidiaries, significantly altering its capital structure and asset base pending closing. The transaction is not subject to a financing condition.
Guidance, Outlook, Risks, and Contingencies
- Closing Conditions: The transaction is subject to customary conditions, including the expiration of the Hart-Scott-Rodino waiting period, receipt of non-U.S. antitrust approvals, and approval from the Federal Communications Commission.
- Termination Rights: The agreement may be terminated if the transaction is not consummated by February 15, 2017 (subject to a three-month extension if regulatory approvals are pending), or if a governmental authority issues a final order preventing the transaction.
- Risks: Risks include the failure to obtain necessary regulatory approvals and the potential for the transaction to be blocked by governmental injunctions.
- Management Commentary: The filing states that the Purchase Agreement contains customary representations and warranties but explicitly notes that these should not be relied upon as characterizations of the actual state of facts by investors.
Investor Verification Checklist
- Verify the status of regulatory approvals, specifically from the Federal Communications Commission and non-U.S. antitrust authorities.
- Confirm the final terms of the $1.3 billion senior unsecured notes and the bridge facility once priced.
- Monitor the February 15, 2017, deadline for transaction consummation and any potential extensions.
- Review the full text of the Share Purchase Agreement (Exhibit 2.1) for specific representations, warranties, and adjustment mechanisms.
- Assess the impact of the $1.7 billion cash outlay on Xylem's future liquidity and leverage ratios.